Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 2, 2021
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS RegisterEmanuele D'Amico, Aurora Zanghì, Marzia Romeo, et al.Journal of Neurology|September 28, 2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world studyLuca Prosperini, Pietro Annovazzi, Laura Boffa, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.Epilepsy Research|August 26, 2019
An Italian multicentre study of perampanel in progressive myoclonus epilepsiesLaura Canafoglia, Giuseppina Barbella, Edoardo Ferlazzo, et al.Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.Seizure|July 23, 2021
Predictive factors of Status Epilepticus and its recurrence in patients with adult-onset seizures: A multicenter, long follow-up cohort studySara Gasparini, Edoardo Ferlazzo, Gianluigi Gigli, et al.Journal of the Neurological Sciences|March 27, 2021
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlationsAntonella Riva, Alessandro Orsini, Marcello Scala, et al.JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.Journal of Neurology|September 20, 2019
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS RegisterDamiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.Annals of Neurology|April 26, 2017
Prognostic indicators in pediatric clinically isolated syndromePietro Iaffaldano, Marta Simone, Giuseppe Lucisano, et al.Pageof 9